Home > Boards > US Listed > Medical - Healthcare >

Gilead Sciences, Inc. (GILD)

GILD RSS Feed
Add GILD Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/4/2019 6:04:26 PM - Followers: 110 - Board type: Free - Posts Today: 0
GILD
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GILD News: Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5 04:01 PM
GILD News: Kite to Present New Data From Leading Cell Therapy Portfolio at ASCO 2019 05/15/2019 05:00:00 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 05/10/2019 06:56:58 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 05/10/2019 05:42:32 PM
GILD News: Statement of Changes in Beneficial Ownership (4) 05/10/2019 05:38:56 PM
News News Alert: Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5 05/21/2019 04:01:00 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#2820   Time to be BULLISH on Gilead Sciences. TopMarketGainers 05/04/19 06:04:26 PM
#2819   GILD 1Q19 CC transcript: DewDiligence 05/03/19 11:11:55 AM
#2818   GILD 1Q19 results: DewDiligence 05/02/19 04:12:27 PM
#2817   GILD’s (second) Selonsertib phase-3 failure in NASH—this time DewDiligence 04/25/19 09:07:41 AM
#2816   ASCO: Outcomes of patients (pts) = 65 years jondoeuk 04/17/19 03:39:00 PM
#2815   "NASH would likely be affecting many if not north40000 04/13/19 01:41:43 AM
#2814   GILD, NVO ink NASH clinical-trial collaboration: DewDiligence 04/12/19 07:48:00 AM
#2812   GILD’s EASL lineup: DewDiligence 03/27/19 09:54:07 AM
#2811   Can Gilead Recover After Latest Earnings Downfall? trding 02/19/19 06:52:35 PM
#2809   I don't have any opinion about him one DewDiligence 02/18/19 08:28:30 PM
#2808   So what are your thoughts on the new LongPennypincher 02/18/19 08:24:18 PM
#2807   Ya, I wonder if there is some bias LongPennypincher 02/18/19 08:22:57 PM
#2806   That write-up is unduly negative on FXR agonists, IMO. DewDiligence 02/18/19 08:14:22 PM
#2804   Page 6 seems pretty interesting.. LongPennypincher 02/18/19 07:46:42 PM
#2802   Is GILD a scam?Of course not. They have, DewDiligence 02/15/19 07:34:47 PM
#2801   Why would you think it a scam? fung_derf 02/12/19 11:44:31 AM
#2799   Is GILD a scam? gi197845 02/11/19 08:28:43 PM
#2798   GILD’s Selonsertib—(ASK1 inhibitor)—fails phase-3 in NASH patients with cirrhosi DewDiligence 02/11/19 05:25:18 PM
#2797   GILD 4Q18 CC slides: DewDiligence 02/04/19 04:35:09 PM
#2796   GILD 4Q18 results: DewDiligence 02/04/19 04:31:32 PM
#2795   AGEN is one of the 1st to satisfy north40000 12/27/18 04:25:03 PM
#2794   GILD, SRRK ink TGFß/fibrosis drug-discovery collaboration: DewDiligence 12/19/18 08:45:22 AM
#2793   GILD’s incoming CEO<—Roche executive, Daniel O’Day (according to WSJ): DewDiligence 12/09/18 08:47:44 PM
#2792   https://finance.yahoo.com/news/china-national-medical-products-administration-133000565.html http north40000 12/04/18 01:01:49 PM
#2791   China also approved another GILD product, DESCOVY: north40000 12/04/18 12:42:03 PM
#2790   China approves Harvoni: DewDiligence 12/04/18 12:30:01 PM
#2788   GILD’s AASLD lineups… DewDiligence 11/09/18 10:54:22 AM
#2786   ASH abstracts https://ash.confex.com/ash/2018/webprogram/Paper117017.html https: jondoeuk 11/03/18 06:37:20 PM
#2785   GILD -5% on UnitedHealthcare’s incentive for patients to DewDiligence 10/31/18 08:18:38 PM
#2784   GILD 3Q18 CC transcript: DewDiligence 10/26/18 10:55:32 AM
#2783   GILD 3Q18 results—HCV sales=$902M,-10% QoQ: DewDiligence 10/25/18 05:05:27 PM
#2781   Dividend($0.57) and earnings PRs: north40000 10/25/18 04:15:25 PM
#2780   Mavyret’s US new-patient share=53.4%—the highest-ever weekly figure—in th DewDiligence 10/12/18 09:10:20 AM
#2779   GILD will launch Harvoni/Epclusa authorized generics for US DewDiligence 09/24/18 10:00:42 AM
#2778   GILD licenses gene-editing approach to HBV from (private) DewDiligence 09/12/18 11:31:45 AM
#2777   GILD News: Confidential Treatment Order (ct Order) 08/16/2018 05:17:29 PM mick 08/18/18 11:35:59 AM
#2776   GILD News: Gilead Sciences Announces Executive Promotions 08/14/2018 05:00:00 PM mick 08/18/18 11:35:52 AM
#2775   GILD News: Statement of Changes in Beneficial Ownership mick 08/18/18 11:35:38 AM
#2774   GILD News: Current Report Filing (8-k) 08/07/2018 03:52:32 PM mick 08/18/18 11:35:21 AM
#2773   GILD News: Quarterly Report (10-q) 08/06/2018 04:20:27 PM mick 08/18/18 11:35:04 AM
#2772   Gilead Sciences, Inc (GILD) mick 08/18/18 11:34:27 AM
#2771   AH filing yesterday: north40000 08/17/18 09:30:28 AM
#2770   https://www.fiercepharma.com/pharma/louisiana-seeking-comments-netflix-model-for north40000 08/17/18 03:29:11 AM
#2769   Transcript of GILD 2Q18 CC: DewDiligence 07/26/18 11:16:41 AM
#2767   GILD 2Q18 CC slides: DewDiligence 07/25/18 05:10:25 PM
#2766   Curious you would say[muse] that...what about HIV, CAR-T(with north40000 07/25/18 05:08:53 PM
#2765   Musings on John Milligan’s departure: DewDiligence 07/25/18 04:57:49 PM
#2764   CEO, John Milligan leaving at year-end: DewDiligence 07/25/18 04:39:55 PM
#2763   GILD 2Q18 results—total HCV sales $1.0B—(-5% QoQ): DewDiligence 07/25/18 04:39:17 PM
#2762   FDA approves Symtuza for HIV: #msg-142267996. DewDiligence 07/17/18 06:29:07 PM
PostSubject